STOCK WARRANTS AND STOCK OPTIONS (Details Narrative) - USD ($) |
1 Months Ended | 3 Months Ended | 12 Months Ended | |||||
---|---|---|---|---|---|---|---|---|
Jan. 03, 2020 |
Aug. 08, 2019 |
Oct. 25, 2019 |
Mar. 31, 2020 |
Mar. 31, 2019 |
Dec. 31, 2019 |
Dec. 31, 2012 |
Oct. 24, 2019 |
|
Non Employee Stock Warrants [Member] | ||||||||
Outstanding executive stock options | 4,800,000 | 19,903,261 | ||||||
Detached free-standing stock warrants granted | 10,582,162 | |||||||
Fair value of detached free-standing stock warrants granted | $ 22,665 | |||||||
Gary Graham [Member] | ||||||||
common stock acquire | $ 800,000 | |||||||
Options vested | 200,000 | 0 | ||||||
Exercise price per share | $ 0.00792 | |||||||
Expected lives | 5 years | |||||||
Michael A. Lanphere [Member] | ||||||||
Outstanding executive stock options | 15,103,261 | |||||||
Reduction in related party debt | $ 65,875 | |||||||
Common stock shares issued to option exercised | 15,103,261 | |||||||
Michael A. Lanphere [Member] | Non employee stock options [Member] | ||||||||
Expected lives | 5 years | |||||||
Loan agreement description | The number of shares to be issued to Mr. Lanphere as a Stock Fee under each Agreement was an estimate and varied based on the loan amount and the price of our common stock on the day of the loan and was calculated by this formula: 60% or 80% of the loan amount divided by the Company’s stock price on the day of the loan, but at a price per share no higher than $0.025. | |||||||
8% Series A-1 Convertible Preferred Stock Investment agreement [Member] | First Capital Ventures "FCV" [Member] | ||||||||
Outstanding executive stock options | 4,800,000 | 4,800,000 | ||||||
Convertible preferred stock shares sold | 1,000,000 | |||||||
Sale of stock price per share | $ 1.00 | |||||||
Common stock shares issuable upon exercise of warrants to SPV | 4,800,000 | |||||||
Exercise price of warrants | $ 0.03125 | |||||||
2019 Equity Incentive Plan [Member] | ||||||||
common stock acquire | $ 76,670,000 | $ 76,000,000 | ||||||
Exercise price per share | ||||||||
Common stock authorized shares | 128,000,000 | |||||||
Stock option vested shares | 21,722,216 | 14,755,287 | ||||||
Stock option non-vested shares | 54,947,784 | 61,244,713 | ||||||
David Gandini [Member] | ||||||||
common stock acquire | $ 24,000,000 | |||||||
Options vested | 3,333,598 | |||||||
Stock options vested | 11,333,330 | 7,999,732 | ||||||
Option vesting terms | (i) 6,666,600 Pre-Vesting Option Shares representing the monthly vesting option shares for the ten months ended October 31, 2019 to vest on November 1, 2019; and (ii) the remaining 1,333,400 Pre-Vesting Option Shares representing the monthly vesting option shares for the two months ended December 31, 2019 shall vest on January 1, 2020 | |||||||
Installments period description | Stock options to vest in 36 equal monthly installments of 666,666 shares during the three-year term of the employment agreement. | |||||||
Exercise price per share | $ 0.00792 | |||||||
Expected lives | 10 years | |||||||
Kevin Moore [Member] | Employment Agreement [Member] | ||||||||
common stock acquire | $ 35,200,000 | |||||||
Options vested | 2,933,331 | |||||||
Stock options vested | 4,888,885 | 1,955,555 | ||||||
Installments period description | Stock options to vest in 36 equal monthly installments of 977,777 shares during the three-year term of the employment agreement. | |||||||
Exercise price per share | $ 0.00792 | |||||||
Expected lives | 3 years | |||||||
Nick Noceti [Member] | ||||||||
common stock acquire | $ 800,000 | |||||||
Options vested | 100,000 | 0 | ||||||
Exercise price per share | $ 0.00792 | |||||||
Expected lives | 5 years | |||||||
Charles Bennington [Member] | ||||||||
common stock acquire | $ 800,000 | |||||||
Options vested | 200,000 | 0 | ||||||
Exercise price per share | $ 0.00792 | |||||||
Expected lives | 5 years | |||||||
Executive Stock Options [Member] | ||||||||
Outstanding executive stock options | 16,722,216 | |||||||
Options exercisable per share | $ 0.00792 |